BIT
CORV

BlackRock Institutional Trust’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

BlackRock Institutional Trust’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$9K Hold
3,184
– – ﹤0.01% 3797
2016
Q3 		$10K Buy
+3,184
New +$11.6K ﹤0.01% 3845
2016
Q2 		– Sell
-3,994
Closed -$16K – 3988
2016
Q1 		$16K Sell
3,994
-2,213
-36% -$11.8K ﹤0.01% 3883
2015
Q4 		$50K Sell
6,207
-18,037
-74% -$150K ﹤0.01% 3813
2015
Q3 		$205K Sell
24,244
-6,444
-21% -$59.3K ﹤0.01% 3641
2015
Q2 		$289K Sell
30,688
-1,969
-6% -$18.3K ﹤0.01% 3586
2015
Q1 		$302K Sell
32,657
-5,149
-14% -$49.3K ﹤0.01% 3584
2014
Q4 		$350K Sell
37,806
-2,155
-5% -$18.1K ﹤0.01% 3568
2014
Q3 		$357K Sell
39,961
-6,817
-15% -$49.6K ﹤0.01% 3540
2014
Q2 		$367K Buy
+46,778
New +$353K ﹤0.01% 3621

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AIS
AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BlackRock Institutional Trust's CORV Position: Q4 2016 in Review

BlackRock Institutional Trust held its Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) position steady in Q4 2016 at 3,184 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #3797.

BlackRock Institutional Trust first reported a position in CORV in Q2 2014 and has held it in 10 quarters since. The position peaked at $367K in Q2 2014. 35 funds tracked by Wall St. Rank hold CORV as of Q4 2016.

  • BlackRock Institutional Trust held 3,184 shares of Correvio Pharma Corp. Ordinary Shares (Canada) worth $9K as of Q4 2016.
  • BlackRock Institutional Trust left its Correvio Pharma Corp. Ordinary Shares (Canada) share count unchanged in Q4 2016.
  • Correvio Pharma Corp. Ordinary Shares (Canada) made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3797 holding.
  • BlackRock Institutional Trust first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2014 and has held it in 10 quarters since.
  • BlackRock Institutional Trust's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $367K in Q2 2014.
  • 35 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.